SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation,Clinical & Translational Immunology

当前位置： X-MOL 学术 › Clin. Transl. Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation
Clinical & Translational Immunology ( IF 5.8 ) Pub Date : 2021-07-05 , DOI: 10.1002/cti2.1306
John Tyler Sandberg ₁ , Renata Varnaitė ₁ , Wanda Christ ₁ , Puran Chen ₁ , Jagadeeswara R Muvva ₁ , Kimia T Maleki ₁ , Marina García ₁ , Majda Dzidic ₁ , Elin Folkesson _{2,

3} , Magdalena Skagerberg _{2,

4} , Gustaf Ahlén ₅ , Lars Frelin ₅ , Matti Sällberg ₅ , Lars I Eriksson _{6,

7} , Olav Rooyackers _{6,

8} , Anders Sönnerborg _{2,

4,

5} , Marcus Buggert ₁ , Niklas K Björkström _{1,

9} , Soo Aleman _{2,

4} , Kristoffer Strålin _{2,

4} , Jonas Klingström ₁ , Hans-Gustaf Ljunggren ₁ , Kim Blom ₁ , Sara Gredmark-Russ _{1,

2} ,

Affiliation

Department of Medicine Huddinge, Center for Infectious Medicine Karolinska Institutet Stockholm Sweden.
Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden.
Department of Medicine Solna, Division of Infectious Diseases Karolinska Institutet Stockholm Sweden.
Division of Infectious Diseases and Dermatology Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden.
Division of Clinical Microbiology, Department of Laboratory Medicine Karolinska Institutet Stockholm Sweden.
Function Perioperative Medicine and Intensive Care Karolinska University Hospital Stockholm Sweden.
Department of Physiology and Pharmacology Karolinska Institutet Stockholm Sweden.
Department of Clinical Science, Technology and Intervention, Division of Anesthesiology and Intensive Care Karolinska Institutet Stockholm Sweden.
Department of Clinical Microbiology Karolinska University Hospital Stockholm Sweden.

Humoral and cellular immunity to SARS-CoV-2 following COVID-19 will likely contribute to protection from reinfection or severe disease. It is therefore important to characterise the initiation and persistence of adaptive immunity to SARS-CoV-2 amidst the ongoing pandemic.

中文翻译：

SARS-CoV-2 特异性体液和细胞免疫持续 9 个月，无论住院时 COVID-19 的严重程度如何

COVID-19 之后对 SARS-CoV-2 的体液和细胞免疫可能有助于防止再感染或严重疾病。因此，重要的是在持续的大流行中表征对 SARS-CoV-2 的适应性免疫的开始和持续存在。

更新日期：2021-07-05

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文

全部期刊列表>>